Explore more publications!

Press Releases

Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care
Biorce closes $52.5MM Series A to accelerate international expansion, lead transformation of clinical trials through AI
Qosina Joins Medical Alley Summit as a Key Sponsor, Connecting with Device Leaders
Palvella Therapeutics Announces Scientific Publication in Clinical and Experimental Dermatology Highlighting a Systematic Review of Real-World Statin Evidence and Persistent Treatment Gaps Resulting from the Lack of FDA-Approved Therapies in Porokeratosis
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
COA Applauds Passing of Multi-Cancer Early Detection Act
EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases
Stabbing Incident Leaves Man Dead Near Leicester City Center

Stabbing Incident Leaves Man Dead Near Leicester City Center

How Automation Is Transforming Service Speed, Revenue in High-Demand Hospitality Environments
Influence Society and Consulate General of France to Host SOCIETIES in New York. A Symposium for Hospitality Leaders
Guidelight Expands to California with Opening of Los Angeles Clinic
Abinopharm, Inc. Releases AbinoNutra® NMN White Paper Following FDA Reinstatement and Human Clinical Trial Evidence
HMP Global’s 2026 LL&M Congress Marks 26th Year of Clinically Actionable Leukemia, Lymphoma, and Myeloma Education
Serotonin Anti-Aging Center to Open Lake Nona Location This Spring, Expanding Orlando Presence
SC MEDICA Announces World’s First 100% Percutaneous, Tubeless Facet Cage Arthrodesis
Independent Medicare Broker Doubles Pro Bono Consults, TEXAS #1 Again, Expands Outreach to Alaska & Upper Midwest
Cold Weather Alert Cancelled - February 5, 2026

Cold Weather Alert Cancelled - February 5, 2026

Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions